close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

812.95 +13.39 (+1.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
2 Mid-Cap Biopharma Stocks BofA Securities Recommends For 2022
Biotech stocks are risky investments and to make a profit informed decision-making is needed. BofA Securities announced its ... 
Via Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple... 
Via Benzinga
Analyst Ratings For argenx
Analysts have provided the following ratings for argenx (NASDAQ:ARGX) withi... 
Via Benzinga
Analyst Ratings For argenx
Analysts have provided the following ratings for argenx (NASDAQ:ARGX) with... 
Via Benzinga
Expert Ratings For argenx
Analysts have provided the following ratings for argenx (NASDAQ:ARGX) with... 
Via Benzinga
What 4 Analyst Ratings Have To Say About argenx
Over the past 3 months, 4 analysts have published their opinion on argenx (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for... 
Via Benzinga
Expert Ratings for argenx
Within the last quarter, argenx (NASDAQ:ARGX) has observed the following a... 
Via Benzinga
Recap: argenx Q2 Earnings
Shares of argenx (NASDAQ:ARGX) decreased 4.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 162.86% over the past... 
Via Benzinga
Analyst Ratings For argenx
Within the last quarter, argenx (NASDAQ:ARGX) has observe... 
Via Benzinga
Where argenx Stands With Analysts
Within the last quarter, argenx (NASDAQ:ARGX) has observe... 
Via Benzinga
What 4 Analyst Ratings Have To Say About argenx
Over the past 3 months, 4 analysts have published their opinion on argenx (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE: 
Via Benzinga
10 Biggest Price Target Changes For Monday
Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (... 
Via Benzinga
Where argenx Stands With Analysts
argenx (NASDAQ:ARGX) has observed the following analyst ra... 
Via Benzinga
Death Cross Looms Over argenx Investors
If history is any guide, there may be trouble ahead for shares of argenx (NASDAQ:ARGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
Upgrades For Preferred Bank (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers OptiNose (NASDAQ:OPTN) stock rose 17.74% to $3.11 during Friday's pre-market session. The company's market cap stands at $165.7 million. DBV Technologies (... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Down; Apple Posts Downbeat Sales
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped more than 200 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Topics Stocks
argenx SE (ARGX) Q3 2021 Earnings Call Transcript
ARGX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
Upgrades BMO Capital upgraded the previous rating for BRP Inc (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
Upgrades For State Street Corporation (NYSE: 
Via Benzinga
argenx SE (ARGX) Q2 2021 Earnings Call Transcript
ARGX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
Upgrades Craig-Hallum upgraded the previous rating for Lindblad Expeditions Holdings Inc (NAS... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021
Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE: 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today